Sophos Group plc is a security software and hardware company. Sophos develops products for communication endpoint, encryption, network security, email security and mobile security as well as unified threat management. Sophos is focused on providing security software to organizations, businesses, and individual users. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Admission to trading on the London Stock Exchange 1 July 2015
LSE: SOPH

17 May
Shore Capital
N/A
Sell

15 May
Deutsche Bank
350.00

Deutsche Bank today reaffirms its buy investment rating on Sophos Group Plc (LON:SOPH) and raised its price target to 430p (from 350p).

JP Morgan Cazenove today reaffirms its overweight investment rating on Sophos Group Plc (LON:SOPH) and raised its price target to 430p (from 360p).

Nice.

Out the spreads @400p back on watch list.

Shares - could go 28% higher.

26 Jun
Morgan Stanley
N/A
Overweight

bought in June at 416 now 34.6% up and rising

Well done. :-))

09:00 27/10/2017
Broker Forecast - JP Morgan Cazenove issues a broker note on Sophos Group Plc
JP Morgan Cazenove today reaffirms its overweight investment rating on Sophos Group Plc (LON:SOPH) and raised its price target to 630p (from 610p). Story provided by StockMarketWire.com

09:40 02/11/2017
Broker Forecast - Jefferies International issues a broker note on Sophos Group Plc
Jefferies International today initiates coverage of Sophos Group Plc (LON:SOPH) with a buy investment rating and price target of 850p. Story provided by StockMarketWire.com

StockMarketWire.com
Sophos Group raised its full-year outlook after billings grew in the first half, though it still reported an operating loss.

The company posted an operating loss of $23.8m, narrowing from a loss of $24.6m in the previous year, as it continued to invest in R&D and sales and marketing activities.

The company now expects 20-22% billings growth for the full year, with a 50-100 basis point improvement in the cash Ebitda margin and modest growth in unlevered free cash flow.

First-half net cash from operations increased by 28% to $80.7m, while billings momentum strengthened, with growth of 22% in the first half and 29% in the second quarter.

Numis comment:
Sophos's Q2 has shown very strong growth, as we expected with our top-of-the-range forecasts. 28% billings growth (NSe 31%) to $177m (NSe $181m) with Cash EBITDA $39m (NSe $41m), 56% growth. FY guidance is raised to 20-22% billings growth (NSe 22% already) thus whilst we expect a c.3-5% increase in consensus, our forecasts remain unchanged at this stage. The standout figure is renewal rate, at 139% by value - given that renewals represent c.60% of billings, a strong renewal rate performance is highly beneficial for overall billings. Importantly, we still see potential for further strong performance from Sophos this year, with strong business momentum as Sophos Central eases the cross/upsell process, and InterceptX provides a highly attractive product for new and existing customers, at a time when well-publicised threats drive demand for such enhanced protection. TP moves up to 570p due to US$ movement.
Sustainability remains the key question. Sophos is benefiting from renewal rates well above historic norms, aided in our view by increasing Central penetration and InterceptX sales. Cybersecurity is such that there are always new threats, thus if Sophos can maintain sufficient product innovation, there will be further new products to sell. Our forecasts assume that renewal rate and growth fades from 2018 onwards -
if we are over-cautious on this, there could be good sustained upside. Conversely, the key risk we see is missing out on a future product cycle transition."

JP Morgan Cazenove today reaffirms its overweight investment rating on Sophos Group Plc (LON:SOPH) and raised its price target to 690p (from 630p).

Jefferies International today reaffirms its buy investment rating on Sophos Group Plc (LON:SOPH) and raised its price target to 865p (from 850p).

Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Interim FY18 GBP Equivalent Dividend Payments
RNS
RNS Number : 3127Y
Sophos Group Plc
04 December 2017
 
Sophos Group plc
 
 
Interim FY18 GBP Equivalent Dividend Payments
 
The Board of Sophos Group plc (Sophos) today announces the GBP equivalent dividend payments in respect of the interim FY18 dividend, which was announced on 8 November 2017 at 1.4 US cents per ordinary share.  The USD to GBP exchange rate used to convert the dividends into GBP of $1.38167348 = £1 is based on the market rate obtained on 1 December 2017. 
 
Accordingly, dividends on ordinary shares will be paid at the rate of 1.013264 pence per ordinary share. This dividend will be payable on 15 December 2017 to those members whose names were on the Register of Members on 17 November 2017.

Director Deals - Sophos Group Plc (SOPH)
BFN
Kris Hagerman, Chief Executive Officer, bought 2,087 shares in the company on the 2nd January 2018 at a price of 376.26p. The Director now holds 849,618 shares.

Story provided by StockMarketWire.com
Director deals data provided by www.directorsholdings.com

Have this company as an entry in the uk stock challenge.

http://www.stockchallenge.co.uk/

11 Jan
Credit Suisse
700.00
Outperform

Edit/ cleared Teach me to read it more. Cheers Harry.

No problem!

Trading statement

Financial and operational highlights

· Billings1 for the nine-month period (year-to-date: "YTD") increased by 21%, or 20% at constant currency ("CC")
- Continued strong growth in Q3, with billings +19% (+14% CC), as we lapped the anniversary of the launch of Intercept X
- Subscription billings increased by 25% YTD, with growth of 20% in Q3
- Sophos Central and Enduser Security remained the principal drivers, with Enduser billings +34% YTD and +27% in Q3
- Network security billings +12% YTD and +15% in Q3
- Good growth across all regions, with Americas and EMEA +22%, and APJ +14% YTD
· Further acceleration in revenue with growth of 19% YTD (18% CC), and 23% in Q3 (19% CC)
- Driven by subscription element of prior-period bookings, with subscription revenue +23% YTD and +27% in Q3
- Deferred revenue increased by 33% year-over-year to $687.6 million
· Strong cash flow performance, with net cash flow from operations up by 21% to $98.2 million and an improvement in unlevered free cash flow2 YTD to $88.2 million, following planned investment in recent new product releases